A portfolio medical technology company, focused on the repair, regeneration, and replacement of soft
and hard tissue, approached Halloran for an organizational assessment inclusive of benchmarking
against other medical technology organizations. The main components of the assessment included a comprehensive review and analysis of their sponsored clinical studies, investigator-initiated studies, medical affairs, and EU Medical Device Regulation (MDR) deliverables.